.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Accenture
Cerilliant
Novartis
Citi
US Department of Justice
Covington
Baxter
Chinese Patent Office
Mallinckrodt
Federal Trade Commission

Generated: September 26, 2017

DrugPatentWatch Database Preview

Natco Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for NATCO PHARMA, and what generic and branded alternatives to NATCO PHARMA drugs are available?

NATCO PHARMA has nineteen approved drugs.

There is one tentative approval on NATCO PHARMA drugs.

Summary for Applicant: Natco Pharma

Patents:0
Tradenames:16
Ingredients:16
NDAs:19
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco Pharma Ltd
ANASTROZOLE
anastrozole
TABLET;ORAL079220-001Jun 28, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
CITALOPRAM HYDROBROMIDE
citalopram hydrobromide
TABLET;ORAL077141-002Apr 10, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
AZACITIDINE
azacitidine
POWDER;IV (INFUSION), SUBCUTANEOUS207234-001Jun 23, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL203478-002Jul 1, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
TRIHEXYPHENIDYL HYDROCHLORIDE
trihexyphenidyl hydrochloride
TABLET;ORAL091630-001Nov 17, 2010AARXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
OSELTAMIVIR PHOSPHATE
oseltamivir phosphate
CAPSULE;ORAL202595-002Aug 3, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
GLYCOPYRROLATE
glycopyrrolate
TABLET;ORAL091413-002Jun 20, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
ONDANSETRON HYDROCHLORIDE
ondansetron hydrochloride
TABLET;ORAL077851-002Jun 25, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma
GRANISETRON HYDROCHLORIDE
granisetron hydrochloride
TABLET;ORAL078969-001Jun 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Natco Pharma Ltd
LETROZOLE
letrozole
TABLET;ORAL200161-001Jun 3, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Accenture
Cerilliant
Mallinckrodt
Cipla
Fuji
Harvard Business School
Cantor Fitzgerald
Covington
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot